Anteris Technologies Global Corp. — Board/Management Information 2022

Mar 2, 2022

ASX ANNOUNCEMENT

3 March 2022

AUSTRALIAN INTERVENTIONAL CARDIOLOGIST JOINS GLOBAL MEDICAL ADVISORY BOARD

Anteris Technologies Ltd (Anteris or the Company) Limited (ASX: AVR) welcomes Dr Karl Poon MB, BS, FRACP, CSANZ to Anteris’ global Medical Advisory Board.

Brisbane based Dr Poon is an experienced interventional cardiologist with expertise in structural heart disease interventions and among Australia's most prolific implanters of TAVI devices.

His Medical Advisory Board participation is a welcome addition as we continue building clinical validation for our novel DurAVR[TM] 3D single-piece transcatheter aortic heart valve.

Dr Poon will receive hands-on experience in DurAVR[TM] implantation at the next cohort of aortic stenosis patients treated at our first-in-human study at the Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia.

“I am pleased Dr Poon has agreed to join our global Medical Advisory Board and will contribute to the ongoing program, gain valuable experience with DurAVR[TM] and help guide us on future studies in all regions, including Australia,” Anteris CEO, Wayne Paterson, said.

ENDS

About Anteris Technologies Ltd (ASX: AVR)

Anteris Technologies Ltd is a structural heart company that delivers clinically superior and durable solutions through better science and better design.

Its focus is developing next-generation technologies that help healthcare professionals reproduce consistent life-changing outcomes for patients.

Anteris’ DurAVR[™] 3D single-piece aortic heart valve replacement addresses the needs of tomorrow’s younger and more active aortic stenosis patients by delivering superior performance and durability through innovations designed to last the remainder of a patient’s lifetime.

The proven benefits of its patented ADAPT[®] tissue technology, paired with the unique design of our DurAVR[™] 3D single-piece aortic heart valve, have the potential to deliver a game-changing treatment to aortic stenosis patients worldwide and provide a much-needed solution to the challenges facing doctors today.

Anteris Technologies Ltd Registered Office:

Toowong Tower, Suite 302, Level 3, 9 Sherwood Rd, Toowong, Queensland, 4066 Customer Service

==> picture [95 x 51] intentionally omitted <==

T +61 1300 550 310 | F +61 1300 972 437 | E info.au@anteristech.com | W anteristech.com Brisbane ▪ Minneapolis ▪ Geneva ▪ Malaga

Authorisation and Additional information

This announcement was authorised by Mr Wayne Paterson, Chief Executive Officer.

For more information:

Hannah Howlett WE Communications E: WE-AUAnterisTech@we-worldwide.com P: +61 4 5064 8064 www.anteristech.com Twitter: @AnterisTech Facebook: www.facebook.com/AnterisTech LinkedIn: https://www.linkedin.com/company/anteristech

==> picture [95 x 52] intentionally omitted <==